New aspects in the management of ANCA-positive vasculitis

Nephrology Dialysis Transplantation

Volumn 16, Issue 7, 2001, Pages 1314-1317

  Levy, Jeremy ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

ANCA; Cyclophosphamide; Immunosuppression; Intravenous immunoglobulin; Leflunomide; Mycophenolate mofetil

Indexed keywords

15 DEOXYSPERGUALIN; ALEMTUZUMAB; AZATHIOPRINE; CD18 ANTIGEN; CD4 ANTIGEN; CD52 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; LYMPHOCYTE ANTIBODY; METHOTREXATE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; STEROID; THYMOCYTE ANTIBODY;

ABDOMINAL PAIN; ALOPECIA; ANEMIA; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW SUPPRESSION; DIARRHEA; EDITORIAL; HOT FLUSH; HUMAN; IMMUNOADSORPTION; INFECTION; INFERTILITY; LEUKOPENIA; LIVER FUNCTION TEST; NAUSEA; PANCYTOPENIA; PLASMAPHERESIS; PNEUMONIA; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTOPENIA; TISSUE INJURY; TRANSITIONAL CELL CARCINOMA; UROTHELIUM; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0034932986     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.7.1314     Document Type: Editorial

References (23)

1. Nomenclature of systemic vasculitides
2. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis
3. Development and initial validation of the vasculitis damage index (VDI) for standardised clinical assessment of damage in the systemic vasculitides
4. European collaborative trials in vasculitides: EUVAS update and latest results
5. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years
6. Relapse rate, renal survival and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement
7. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: A prospective, randomized study
8. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis
9. Still a role for plasma exchange in rapidly progressive glomerulonephritis
10. Long term outcome after immunosuppression and plasma exchange for severe vasculitis associated glomerulonephritis
11. Cyclosporin for the prevention of disease reactivation in relapsing ANCA-associated vasculitis
12. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity
13. Treatment of 13 patients with vasculitis and other autoimmune diseases with intravenous immunoglobulin
14. An analysis of 42 Wegeners granulomatosis patients treated with methotrexate and prednisone
15. Mycophenolate mofetil for maintenance therapy of Wegeners granulomatosis and microscopic polyangiitis, a pilot study in 11 patients with renal involvement
16. Preliminary results of a pilot study on the use of Mycophenolate Mofetil in relapsing ANCA small vessel vasculitis
17. Mycophenolate mofetil for remission induction in patients with active Wegener's granulomatosis intolerant of cyclophosphamide
18. 15-Deoxyspergualin induces remission in Wegener's granulomatosis
19. Treatment of refractory Wegener's granulomatosis with humanised monoclonal antibodies
20. Antithymocyte globulin: A therapeutic option for Wegener's granulomatosis untreatable with conventional therapies
21. Anti-adhesion molecule therapy as an interventional strategy for autoimmune inflammation
22. Semi-specific immuno-absorption and monoclonal antibody therapy in ANCA positive vasculitis: Experience in four cases
23. Specific MPO immunoabsorption for the treatment of vasculitis